These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 2138532)
1. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Talley NJ; Phillips SF; Haddad A; Miller LJ; Twomey C; Zinsmeister AR; MacCarty RL; Ciociola A Dig Dis Sci; 1990 Apr; 35(4):477-80. PubMed ID: 2138532 [TBL] [Abstract][Full Text] [Related]
2. Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides. Talley NJ; Phillips SF; Haddad A; Miller LJ; Twomey C; Zinsmeister AR; Ciociola A Dig Dis Sci; 1989 Oct; 34(10):1511-5. PubMed ID: 2529108 [TBL] [Abstract][Full Text] [Related]
3. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Steadman CJ; Talley NJ; Phillips SF; Zinsmeister AR Mayo Clin Proc; 1992 Aug; 67(8):732-8. PubMed ID: 1434911 [TBL] [Abstract][Full Text] [Related]
4. Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist. Gore S; Gilmore IT; Haigh CG; Brownless SM; Stockdale H; Morris AI Aliment Pharmacol Ther; 1990 Apr; 4(2):139-44. PubMed ID: 2151757 [TBL] [Abstract][Full Text] [Related]
5. A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. von der Ohe MR; Camilleri M; Kvols LK Gastroenterology; 1994 May; 106(5):1184-9. PubMed ID: 8174881 [TBL] [Abstract][Full Text] [Related]
6. Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. von der Ohe MR; Hanson RB; Camilleri M Gut; 1994 Apr; 35(4):536-41. PubMed ID: 8174993 [TBL] [Abstract][Full Text] [Related]
7. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590 [TBL] [Abstract][Full Text] [Related]
8. Proximal and distal gut hormone secretion in slow transit constipation. Penning C; Delemarre JB; Bemelman WA; Biemond I; Lamers CB; Masclee AA Eur J Clin Invest; 2000 Aug; 30(8):709-14. PubMed ID: 10964163 [TBL] [Abstract][Full Text] [Related]
9. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome. Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764 [TBL] [Abstract][Full Text] [Related]
10. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers. Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. Cubeddu LX; Hoffmann IS; Fuenmayor NT; Finn AL N Engl J Med; 1990 Mar; 322(12):810-6. PubMed ID: 1689807 [TBL] [Abstract][Full Text] [Related]